EMPLIMET XR 2.5/12.5/1000MG TAB NEW

EMPLIMET XR 2.5/12.5/1000MG is a fixed-dose combination tablet containing Empagliflozin, Linagliptin, and Metformin HCL. This extended-release formulation is designed for managing type 2 diabetes mellitus in patients requiring multi-mechanism glycemic control. The combination works through three distinct pathways: SGLT2 inhibition, DPP-4 inhibition, and biguanide action, offering comprehensive blood sugar management. Suitable for adults whose diabetes is not adequately controlled with monotherapy or dual therapy. Each tablet delivers sustained therapeutic effect throughout the day. Always follow prescribed dosage and consult your healthcare provider for proper usage and monitoring.